CCL20 and lung carcinoma: For example, Da Silva et al. designed a biodegradable nanoparticle and used it as a delivery vehicle for doxorubicin, two immune adjuncts, and CCL20 for treating resistant TC-1 lung carcinoma and MC-38 colon adenocarcinoma.